Investor Guides
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Trajan Group.
RELATED STOCKHEAD STORIES
Health & Biotech
Aussie made: ASX firms boosting local health & medical manufacturing
Health & Biotech
Microcap with a Blue-Chip profile: Trajan Group is growing through key acquisitions, partnerships and collaborations
News
Market Highlights: Wall Street defies Powell’s hawkish comments; and 5 stocks to watch on the ASX today
Experts
SUNDAY ROAST: The small caps that lit a fire under Stockhead’s experts this week
Experts
MoneyTalks: Brokers love these ASX listed automotive and scientific instrument stocks
Health & Biotech
ASX Health Stocks: Trajan delivers another strong half as it upgrades guidance
News
Top 10 at 10: The ASX stocks sprinting and stumbling in early trade Monday
Health & Biotech
Check Up: Only two healthcare IPOs from 2021 are gaining ground, could the rest be buying opportunities?
Health & Biotech
ASX Health Stocks: Giant Sonic and small cap Probiotic roll out the record results
Health & Biotech
ASX Health Stocks: Trajan rattles the tin in further $5 million cap raise
Health & Biotech
ASX Health Stocks: Kazia Therapeutics gets crucial designation status from the US FDA
Health & Biotech
ASX Health Stocks: Here’s a highlight from today’s half-year result announcements
Health & Biotech
ASX Health Stocks: Mesoblast responds to questions arising from US FDA meeting
News
Closing Bell: December on track to be the ASX’s second best month of 2021
Health & Biotech
Healthcare has been a hot sector. Here are the top ASX biotech stocks in 2021
Health & Biotech
ScoPo’s Powerplays: Neuren breakthrough, M&A deals, and why EBOS ticks ESG boxes
News
